| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.08 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.078 | 0.09 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.09 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.27 | 0.1 |